Hepatitis D ultrasound

Revision as of 22:38, 14 February 2018 by Ahmed Younes (talk | contribs)
Jump to navigation Jump to search

Hepatitis Main Page

Hepatitis D

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis D ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis D ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis D ultrasound

CDC on Hepatitis D ultrasound

Hepatitis D ultrasound in the news

Blogs on Hepatitis D ultrasound

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]

Overview

The liver ultrasound of a patient with hepatitis D may reveal unspecific findings, such as: hepatomegaly, gallbladder wall thickening, increased echogenicity, and signs of portal hypertension. It may also be used in the diagnosis and monitoring of hepatic cirrhosis, as well as for hepatocellular carcinoma. Attending to the simultaneous occurrence of HDV and HBV, HBsAg carriers with cirrhosis should be echographically evaluated every 6 months.[1]

Ultrasound

Although unspecific, the following findings may be identified in patients with hepatitis D:[1][2][3][4]

In advanced stages of the disease, in which cirrhosis might be present, the following findings may be identified:

  • Liver shape abnormalities
  • Parenchymal heterogeneity
  • Nodularity of liver surface

HBsAg carriers should have regular determinations of serum alpha-fetoprotein. Ultrasound examinations should be performed in patients above 40 years of age (with 6 month intervals). These tests should be repeated regularly in all patients who are HBsAg positive, with cirrhosis.[1]

Ultrasound is also useful for the diagnosis and monitoring of hepatocellular carcinoma, a potential complication of hepatitis D.

References

  1. 1.0 1.1 1.2 "Hepatitis D" (PDF).
  2. Ferral H, Male R, Cardiel M, Munoz L, Quiroz y Ferrari F (1992). "Cirrhosis: diagnosis by liver surface analysis with high-frequency ultrasound". Gastrointest Radiol. 17 (1): 74–8. doi:10.1007/BF01888512. PMID 1544561.
  3. Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ (1999). "The value of Doppler ultrasound in cirrhosis and portal hypertension". Scand J Gastroenterol Suppl. 230: 82–8. PMID 10499467.
  4. Tchelepi H, Ralls PW, Radin R, Grant E (2002). "Sonography of diffuse liver disease". J Ultrasound Med. 21 (9): 1023–32, quiz 1033-4. PMID 12216750.

Template:WH Template:WS